New Adjuvants for Parenteral and Mucosal Vaccines
Thérapie, 60 3 (2005) 235-241
Published online: 2007-03-01
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
241 (2025)
https://doi.org/10.2174/9789815324570125010011
Evaluation of immunogenicity and protection mediated by Lawsonia intracellularis subunit vaccines
Kezia R. Fourie, Pooja Choudhary, Siew Hon Ng, Milan Obradovic, Robert Brownlie, Sanjeev K. Anand and Heather L. WilsonVeterinary Immunology and Immunopathology 237 110256 (2021)
https://doi.org/10.1016/j.vetimm.2021.110256
315 (2021)
https://doi.org/10.1007/978-981-33-6236-9_14
An immunopotentiator, ophiopogonin D, encapsulated in a nanoemulsion as a robust adjuvant to improve vaccine efficacy
Ya-nan Tong, Liu-yang Yang, Yun Yang, Zhen Song, Liu-sheng Peng, Ji-ning Gao, Hao Zeng, Quan-ming Zou, Hong-wu Sun and Xu-hu MaoActa Biomaterialia 77 255 (2018)
https://doi.org/10.1016/j.actbio.2018.07.034
Intranasal vaccination with an adjuvanted polyphosphazenes nanoparticle-based vaccine formulation stimulates protective immune responses in mice
Kai Schulze, Thomas Ebensen, Lorne A. Babiuk, Volker Gerdts and Carlos A. GuzmanNanomedicine: Nanotechnology, Biology and Medicine 13 (7) 2169 (2017)
https://doi.org/10.1016/j.nano.2017.05.012
A subunit vaccine based on rH-NS induces protection against Mycobacterium tuberculosis infection by inducing the Th1 immune response and activating macrophages
Yuan Liu, Suting Chen, Bowen Pan, et al.Acta Biochimica et Biophysica Sinica 48 (10) 909 (2016)
https://doi.org/10.1093/abbs/gmw078
The Second Messenger Cyclic Di-GMP
Thomas Ebensen, Rimma Libanova and Carlos A. GuzmánThe Second Messenger Cyclic Di-GMP 311 (2014)
https://doi.org/10.1128/9781555816667.ch22
Antimicrobial peptide elicitors: New hope for the post-antibiotic era
Ernesto Prado Montes de OcaInnate Immunity 19 (3) 227 (2013)
https://doi.org/10.1177/1753425912460708
Bis-(3′,5′)-cyclic dimeric adenosine monophosphate: Strong Th1/Th2/Th17 promoting mucosal adjuvant
Thomas Ebensen, Rimma Libanova, Kai Schulze, et al.Vaccine 29 (32) 5210 (2011)
https://doi.org/10.1016/j.vaccine.2011.05.026
A Novel, Killed-Virus Nasal Vaccinia Virus Vaccine
Anna U. Bielinska, Alexander A. Chepurnov, Jeffrey J. Landers, et al.Clinical and Vaccine Immunology 15 (2) 348 (2008)
https://doi.org/10.1128/CVI.00440-07
T cell independent mechanism for copolymer‐1‐induced neuroprotection
Jianuo Liu, Thomas V. Johnson, Jamie Lin, Servio H. Ramirez, Tatiana K. Bronich, Steve Caplan, Yuri Persidsky, Howard E. Gendelman and Jonathan KipnisEuropean Journal of Immunology 37 (11) 3143 (2007)
https://doi.org/10.1002/eji.200737398
The Bacterial Second Messenger cdiGMP Exhibits Promising Activity as a Mucosal Adjuvant
Thomas Ebensen, Kai Schulze, Peggy Riese, Michael Morr and Carlos A. GuzmánClinical and Vaccine Immunology 14 (8) 952 (2007)
https://doi.org/10.1128/CVI.00119-07
Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza
Peter Pushko, Terrence M. Tumpey, Neal Van Hoeven, et al.Vaccine 25 (21) 4283 (2007)
https://doi.org/10.1016/j.vaccine.2007.02.059
The bacterial second messenger cyclic diGMP exhibits potent adjuvant properties
Thomas Ebensen, Kai Schulze, Peggy Riese, et al.Vaccine 25 (8) 1464 (2007)
https://doi.org/10.1016/j.vaccine.2006.10.033
A Pegylated Derivative of α-Galactosylceramide Exhibits Improved Biological Properties
Thomas Ebensen, Claudia Link, Peggy Riese, Kai Schulze, Michael Morr and Carlos A. GuzmánThe Journal of Immunology 179 (4) 2065 (2007)
https://doi.org/10.4049/jimmunol.179.4.2065